Adaptive Radiotherapy Clinical Trials

8 recruiting

Adaptive Radiotherapy Trials at a Glance

9 actively recruiting trials for adaptive radiotherapy are listed on ClinicalTrialsFinder across 6 cities in 3 countries. The largest study group is Not Applicable with 5 trials, with the heaviest enrollment activity in Guangzhou, Essen, and Changsha. Lead sponsors running adaptive radiotherapy studies include University Hospital, Essen, Sun Yat-sen University, and Cancer Institute and Hospital, Chinese Academy of Medical Sciences.

Browse adaptive radiotherapy trials by phase

Treatments under study

About Adaptive Radiotherapy Clinical Trials

Looking for clinical trials for Adaptive Radiotherapy? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Adaptive Radiotherapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Adaptive Radiotherapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 19 of 9 trials

Recruiting
Phase 2

The Efficacy and Safety of the Combination of PD-1 With Chemotherapy and Adaptive Radiotherapy Strategy in the Treatment of Stage III Non-small Cell Lung Cancer Patients

NSCLCSintilimabAdaptive Radiotherapy
The Third Xiangya Hospital of Central South University35 enrolled1 locationNCT07138755
Recruiting
Not Applicable

MR-linac Guided Ultra-hypofractionated RT for Prostate Cancer (SMART-P01 and SMART-P02)

Radiotherapy Side EffectProstate CancerOligometastatic Disease+4 more
Cancer Institute and Hospital, Chinese Academy of Medical Sciences50 enrolled1 locationNCT05183074
Recruiting
Not Applicable

Efficiency of Contemporary Off-line Adaptive Radiotherapy for Lung Cancer

NSCLC (Advanced Non-small Cell Lung Cancer)Adaptive Radiotherapy
Universitaire Ziekenhuizen KU Leuven30 enrolled1 locationNCT07259447
Recruiting
Phase 2

Elimination of PTV Margins Based on MRI-guided Adaptive Stereotactic Radiotherapy for Non-small Cell Lung Cancer With Brain Metastasis

Non-small Cell Lung CancerBrain MetastasisMRI-guided Adaptive Radiotherapy
Sun Yat-sen University168 enrolled1 locationNCT06582940
Recruiting
Phase 2

Elimination of PTV Margins Based on Online Adaptive Stereotactic Radiotherapy for Early-stage Non-small Cell Lung Cancer or Pulmonary Oligometastases

Non-small Cell Lung CancerToxicityAdaptive Radiotherapy+2 more
Sun Yat-sen University130 enrolled1 locationNCT06542159
Recruiting
Phase 3

Moderated Hypofractionated Online Adaptive Radiotherapy in Cervical Cancer

Cervical CancerAdaptive Radiotherapy
Peking Union Medical College Hospital440 enrolled1 locationNCT06641635
Recruiting
Not Applicable

Prospective Validation of Adaptive Radiotherapy (ART) in Patients With Head and Neck Tumors

RadiationHead and Neck CancerAdaptive Radiotherapy+3 more
University Hospital, Essen50 enrolled1 locationNCT06214611
Recruiting
Not Applicable

Adaptive Radiotherapy in Head and Neck Tumor Patients

Head and Neck CancerHead and Neck NeoplasmsAdaptive Radiotherapy+1 more
University Hospital, Essen30 enrolled1 locationNCT06216171
Recruiting
Not Applicable

Adaptive Radiotherapy in Patients With Gynecological Tumors

RadiationCervical CarcinomaAdaptive Radiotherapy+5 more
University Hospital, Essen30 enrolled1 locationNCT06230549